The Life Sciences sector is excelling, with 71% of stocks in the sector currently rated a 'Buy' by Wall Street analysts. Scott Smith is the Managing Director of the Wedbush PacGrow Life Sciences Investment Banking group and spoke with TheStreet's Susannah Lee on the trends he's seeing in the sector. Smith has led numerous transactions for life science companies including IPOs and tells us the trends he's seeing investment activity for the sector. Smith also shares with us what he heard at their latest conference on which stocks investors are liking at the moment including Applied Genetic Technologies (AGTC) and Cardica (CRDC).

More from Video

Future of Fast Food: Wendy's CEO Dishes

Future of Fast Food: Wendy's CEO Dishes

Outdoorsy Figured Out How to Make Money Off That Idle RV in Your Driveway

Outdoorsy Figured Out How to Make Money Off That Idle RV in Your Driveway

Jim Cramer: Aramark Is a Great Company but It's Levered to Baseball

Jim Cramer: Aramark Is a Great Company but It's Levered to Baseball

It's Not Over Yet: Keep an Eye on FANG Stocks

It's Not Over Yet: Keep an Eye on FANG Stocks

Jim Cramer on the Markets: 2:45pm Is a Make or Break Level

Jim Cramer on the Markets: 2:45pm Is a Make or Break Level